Find-Health-Articles.com - making medical research available to everyone

Biogenic Monoamines
Research News and Information

Definition of 'Biogenic Monoamines'

Biogenic amines having only one amine moiety. Included in this group are all natural monoamines formed by the enzymatic decarboxylation of natural amino acids.

Common names: Biogenic Monoamines; Monoamines, Biogenic

More technical Information...

Saturday, November 21, 2009

Sleep disorders in Parkinson's disease: the contribution of the MPTP non-human primate model.

23 Jul 2009 To replicate the sleep-wake disorders of Parkinson's disease (PD) and to understand the temporal relationship between these sleep disturbances and the occurrence of parkinsonism, we performed long-term continuous electroencephalographic monitoring ... Read more...


Emerging targets for antidepressant therapies.

4 Jun 2009 Despite adequate antidepressant monotherapy, the majority of depressed patients do not achieve remission. Even optimal and aggressive therapy leads to a substantial number of patients who show minimal and often only transient improvement. In order ... Read more...


Caulis Sinomenii extracts activate DA/NE transporter and inhibit 5HT transporter.

31 May 2009 Caulis Sinomenii (QFT) has analgesic, sedative, and anxiolytic-like actions, and is proven effective for improving drug dependence that is known to be associated with abnormal monoaminergic transmission. We assessed whether QFT would be biologically ... Read more...

 

Latest indexed articles for 'Biogenic Monoamines'

These are the very latest articles for this heading:

See a longer list of these articles.

Technical information about 'Biogenic Monoamines'

Definition: Biogenic amines having only one amine moiety. Included in this group are all natural monoamines formed by the enzymatic decarboxylation of natural amino acids.

Registry Number: 0

Descriptor UI: D015306

Alternative terms: Biogenic Monoamines; Monoamines, Biogenic;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists; biosynthesis; physiology;

Tree Number: D02.092.211.215;

History Note: 89

Technical Notes: general: prefer specifics

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index